Literature DB >> 12434893

Effects of magnesium sulphate on amplitude-integrated continuous EEG in asphyxiated term neonates.

F Groenendaal1, C M A Rademaker, M C Toet, L S de Vries.   

Abstract

UNLABELLED: In this study it is hypothesized that magnesium sulphate in asphyxiated full-term neonates could lead to a gradual improvement in background pattern of the amplitude integrated EEG (aEEG), an early marker of hypoxic-ischaemic brain injury. In a double-blind, randomized, controlled pilot study of 22 asphyxiated full-term neonates 8 received magnesium sulphate, reaching serum Mg2+ levels of 2.5 mmol/L. Magnesium sulphate had no immediate effect on aEEG-patterns. At 12 h of age, aEEG was more depressed compared with aEEG at 3 h in 6 of the 8 magnesium-treated neonates, and in 3 of the 14 placebo-treated neonates (Mg2+ vs placebo: p < 0.05, Mann-Whitney). No further significant changes in aEEG were seen between 12 and 24 h. Outcome was unfavourable in 4 of the 8 magnesium-treated neonates, and in 8 of the 14 placebo-treated neonates.
CONCLUSION: Magnesium sulphate did not have a positive effect on aEEG patterns in this small group of asphyxiated term neonates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12434893     DOI: 10.1080/080352502760311575

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  11 in total

1.  Time and sex dependent effects of magnesium sulphate on post-asphyxial seizures in preterm fetal sheep.

Authors:  Laura Bennet; Robert Galinsky; Vittoria Draghi; Christopher A Lear; Joanne O Davidson; Charles P Unsworth; Alistair J Gunn
Journal:  J Physiol       Date:  2018-04-16       Impact factor: 5.182

Review 2.  Neuroprotection Strategies for Term Encephalopathy.

Authors:  Fernando F Gonzalez
Journal:  Semin Pediatr Neurol       Date:  2019-08-07       Impact factor: 1.636

3.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 4.  Neuroprotection in the newborn infant.

Authors:  Fernando F Gonzalez; Donna M Ferriero
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

Review 5.  Brain resuscitation in the drowning victim.

Authors:  Alexis A Topjian; Robert A Berg; Joost J L M Bierens; Christine M Branche; Robert S Clark; Hans Friberg; Cornelia W E Hoedemaekers; Michael Holzer; Laurence M Katz; Johannes T A Knape; Patrick M Kochanek; Vinay Nadkarni; Johannes G van der Hoeven; David S Warner
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

6.  Magnesium sulfate reduces EEG activity but is not neuroprotective after asphyxia in preterm fetal sheep.

Authors:  Robert Galinsky; Vittoria Draghi; Guido Wassink; Joanne O Davidson; Paul P Drury; Christopher A Lear; Alistair J Gunn; Laura Bennet
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Magnesium treatment for neuroprotection in ischemic diseases of the brain.

Authors:  Thomas Westermaier; Christian Stetter; Ekkehard Kunze; Nadine Willner; Furat Raslan; Giles H Vince; Ralf-Ingo Ernestus
Journal:  Exp Transl Stroke Med       Date:  2013-04-25

8.  Magnesium for neuroprotection in birth asphyxia.

Authors:  Geeta Gathwala; Atul Khera; Jagjit Singh; Bharti Balhara
Journal:  J Pediatr Neurosci       Date:  2010-07

9.  Increased concentrations of both NMDA receptor co-agonists D-serine and glycine in global ischemia: a potential novel treatment target for perinatal asphyxia.

Authors:  Sabine A Fuchs; Cacha M P C D Peeters-Scholte; Martina M J de Barse; Martin W Roeleveld; Leo W J Klomp; Ruud Berger; Tom J de Koning
Journal:  Amino Acids       Date:  2011-09-23       Impact factor: 3.520

10.  Magnesium sulphate for newborns with HIE; synopsis of evidence from a systematic review.

Authors:  Jasim Anabrees
Journal:  J Clin Neonatol       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.